We're thrilled to announce that Discovery Immunology, our broad-scope Open Access journal for new discoveries in cellular and molecular immunology, has achieved a significant milestone. The newest journal in the BSI publishing portfolio is now indexed in PubMed Central, one of the largest and most widely used repositories for biomedical and life sciences articles. You can access the dedicated page on PubMed Central.
This indexing in PubMed Central marks a crucial step forward for Discovery Immunology, allowing its high-quality articles to reach an even wider audience. All articles published since the journal’s launch in 2022 are now fully searchable and accessible to all.
With this achievement, our vision for Discovery Immunology as an invaluable resource providing the global immunology community with trusted new insights into the workings of the immune system, is becoming a reality.
Thank you to the editorial team brilliantly led by Founding Editor-in-Chief Professor Simon Milling for their hard work and commitment to building strong foundations for the journal. Together, we also thank authors, reviewers and readers for their incredible support. Our next objective is to achieve indexing in all widely used services, including Scopus and the Web of Science.
We would like to use this opportunity to encourage our members and the wider immunology community to continue supporting Discovery Immunology whilst we grow our international visibility by submitting your latest research. Thank you to all of those who have already published their work – your contributions are essential. You can also contribute to the growth of the journal by reading, sharing and citing our articles where appropriate, to help our content reach an even wider audience.
Discovery Immunology publishes high-quality original research, reviews and short reports describing novel mechanisms controlling the immune response. We offer a quick turnaround from our supportive editorial team and, when accepted, your article would appear in PMC very soon after entering production. Explore the journal’s latest content and submit your own article.
We offer all BSI members a 20% discount on publication fees for Discovery Immunology. You may also be able to publish your paper using funds available through Read and Publish deals with organisations from our publisher, Oxford University Press.
When you publish in our official journals, the profits are reinvested back into the BSI membership and our immunology community through the BSI grants, support of Regional and Affinity Group activities, travel awards, the BSI Congress and much more.
Find out more
- Visit the Discovery Immunology website
- Join the conversation online by following @discovimmunol
- Submit your article to be featured in Discovery Immunology’s upcoming collection on ecoimmunology
- Read the latest Special Collection on checkpoint molecules in cancer immunotherapy